Michael J McGeachie1,2, Katherine P Yates3, Xiaobo Zhou1,2, Feng Guo1,2, Alice L Sternberg3, Mark L Van Natta3, Robert A Wise4, Stanley J Szefler5,6, Sunita Sharma7, Alvin T Kho1,2,8, Michael H Cho1,2, Damien C Croteau-Chonka1,2, Peter J Castaldi1,2, Gaurav Jain9, Amartya Sanyal9,10, Ye Zhan9, Bryan R Lajoie9, Job Dekker11, John Stamatoyannopoulos12, Ronina A Covar5,6,13, Robert S Zeiger14,15, N Franklin Adkinson4, Paul V Williams16, H William Kelly17, Hartmut Grasemann18, Judith M Vonk19, Gerard H Koppelman20, Dirkje S Postma21, Benjamin A Raby1,2, Isaac Houston1,2, Quan Lu22, Anne L Fuhlbrigge1,23,2, Kelan G Tantisira1,2, Edwin K Silverman1,2, James Tonascia3, Robert C Strunk24, Scott T Weiss1,2. 1. 1 Channing Division of Network Medicine and. 2. 2 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 3. 3 Bloomberg School of Public Health and. 4. 4 School of Medicine, Johns Hopkins University, Baltimore, Maryland. 5. 5 National Jewish Health and Research Center, Denver, Colorado. 6. 6 Children's Hospital Colorado and. 7. 7 Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Denver, Colorado. 8. 8 Boston Children's Hospital, Boston, Massachusetts. 9. 9 Program in Systems Biology, Department of Biochemistry and Molecular Pharmacology, and. 10. 10 School of Biological Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. 11. 11 Howard Hughes Medical Institute, Program in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts. 12. 12 Genome Sciences, School of Medicine, University of Washington, Seattle, Washington. 13. 13 University of Colorado, Denver, Colorado. 14. 14 Department of Pediatrics, University of California at San Diego, La Jolla, California. 15. 15 Kaiser Permanente Southern California Region, San Diego, California. 16. 16 ASTHMA, Inc., Clinical Research Center and Northwest Asthma & Allergy Center, Seattle, Washington. 17. 17 University of New Mexico Health Sciences Center, Albuquerque, New Mexico. 18. 18 Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Toronto, Canada. 19. 19 Department of Epidemiology. 20. 20 Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, and. 21. 21 Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands. 22. 22 Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health and Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; and. 23. 23 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 24. 24 Division of Allergy, Immunology, and Pulmonary Medicine, Washington University School of Medicine, St. Louis, Missouri.
Abstract
RATIONALE: Patterns of longitudinal lung function growth and decline in childhood asthma have been shown to be important in determining risk for future respiratory ailments including chronic airway obstruction and chronic obstructive pulmonary disease. OBJECTIVES: To determine the genetic underpinnings of lung function patterns in subjects with childhood asthma. METHODS: We performed a genome-wide association study of 581 non-Hispanic white individuals with asthma that were previously classified by patterns of lung function growth and decline (normal growth, normal growth with early decline, reduced growth, and reduced growth with early decline). The strongest association was also measured in two additional cohorts: a small asthma cohort and a large chronic obstructive pulmonary disease metaanalysis cohort. Interaction between the genomic region encompassing the most strongly associated single-nucleotide polymorphism and nearby genes was assessed by two chromosome conformation capture assays. MEASUREMENTS AND MAIN RESULTS: An intergenic single-nucleotide polymorphism (rs4445257) on chromosome 8 was strongly associated with the normal growth with early decline pattern compared with all other pattern groups (P = 6.7 × 10-9; odds ratio, 2.8; 95% confidence interval, 2.0-4.0); replication analysis suggested this variant had opposite effects in normal growth with early decline and reduced growth with early decline pattern groups. Chromosome conformation capture experiments indicated a chromatin interaction between rs4445257 and the promoter of the distal CSMD3 gene. CONCLUSIONS: Early decline in lung function after normal growth is associated with a genetic polymorphism that may also protect against early decline in reduced growth groups. Clinical trial registered with www.clinicaltrials.gov (NCT00000575).
RATIONALE: Patterns of longitudinal lung function growth and decline in childhood asthma have been shown to be important in determining risk for future respiratory ailments including chronic airway obstruction and chronic obstructive pulmonary disease. OBJECTIVES: To determine the genetic underpinnings of lung function patterns in subjects with childhood asthma. METHODS: We performed a genome-wide association study of 581 non-Hispanic white individuals with asthma that were previously classified by patterns of lung function growth and decline (normal growth, normal growth with early decline, reduced growth, and reduced growth with early decline). The strongest association was also measured in two additional cohorts: a small asthma cohort and a large chronic obstructive pulmonary disease metaanalysis cohort. Interaction between the genomic region encompassing the most strongly associated single-nucleotide polymorphism and nearby genes was assessed by two chromosome conformation capture assays. MEASUREMENTS AND MAIN RESULTS: An intergenic single-nucleotide polymorphism (rs4445257) on chromosome 8 was strongly associated with the normal growth with early decline pattern compared with all other pattern groups (P = 6.7 × 10-9; odds ratio, 2.8; 95% confidence interval, 2.0-4.0); replication analysis suggested this variant had opposite effects in normal growth with early decline and reduced growth with early decline pattern groups. Chromosome conformation capture experiments indicated a chromatin interaction between rs4445257 and the promoter of the distal CSMD3 gene. CONCLUSIONS: Early decline in lung function after normal growth is associated with a genetic polymorphism that may also protect against early decline in reduced growth groups. Clinical trial registered with www.clinicaltrials.gov (NCT00000575).
Entities:
Keywords:
CSMD3; asthma; chronic obstructive pulmonary disease; genome-wide association studies; longitudinal lung function patterns
Authors: Dirkje S Postma; Deborah A Meyers; Hajo Jongepier; Timothy D Howard; Gerard H Koppelman; Eugene R Bleecker Journal: Am J Respir Crit Care Med Date: 2005-05-18 Impact factor: 21.405
Authors: M J McGeachie; K P Yates; S T Weiss; R C Strunk; X Zhou; F Guo; A L Sternberg; M L Van Natta; R A Wise; S J Szefler; S Sharma; A T Kho; M H Cho; D C Croteau-Chonka; P J Castaldi; G Jain; A Sanyal; Y Zhan; B R Lajoie; J Dekker; J Stamatoyannopoulos; R A Covar; R S Zeiger; N F Adkinson; P V Williams; H W Kelly; H Grasemann; J M Vonk; G H Koppelman; D S Postma; B A Raby; I Houston; Q Lu; A L Fuhlbrigge; K G Tantisira; E K Silverman; J Tonascia Journal: N Engl J Med Date: 2016-05-12 Impact factor: 91.245
Authors: Sunita Sharma; Kelan Tantisira; Vincent Carey; Amy J Murphy; Jessica Lasky-Su; Juan C Celedón; Ross Lazarus; Barbara Klanderman; Angela Rogers; Manuel Soto-Quirós; Lydiana Avila; Thomas Mariani; Roger Gaedigk; Stephen Leeder; John Torday; David Warburton; Benjamin Raby; Scott T Weiss Journal: Am J Respir Crit Care Med Date: 2009-11-19 Impact factor: 21.405
Authors: Kentaro Mizuta; Dingbang Xu; Yaping Pan; George Comas; Joshua R Sonett; Yi Zhang; Reynold A Panettieri; Jay Yang; Charles W Emala Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-04-11 Impact factor: 5.464
Authors: Megan Hardin; Michael Cho; Merry-Lynn McDonald; Terri Beaty; Joe Ramsdell; Surya Bhatt; Edwin J R van Beek; Barry J Make; James D Crapo; Edwin K Silverman; Craig P Hersh Journal: Eur Respir J Date: 2014-05-29 Impact factor: 16.671
Authors: Robert Petryszak; Tony Burdett; Benedetto Fiorelli; Nuno A Fonseca; Mar Gonzalez-Porta; Emma Hastings; Wolfgang Huber; Simon Jupp; Maria Keays; Nataliya Kryvych; Julie McMurry; John C Marioni; James Malone; Karine Megy; Gabriella Rustici; Amy Y Tang; Jan Taubert; Eleanor Williams; Oliver Mannion; Helen E Parkinson; Alvis Brazma Journal: Nucleic Acids Res Date: 2013-12-04 Impact factor: 16.971
Authors: Michael A Portelli; Mateusz Siedlinski; Ceri E Stewart; Dirkje S Postma; Maartje A Nieuwenhuis; Judith M Vonk; Peter Nurnberg; Janine Altmuller; Miriam F Moffatt; Andrew J Wardlaw; Stuart G Parker; Martin J Connolly; Gerard H Koppelman; Ian Sayers Journal: FASEB J Date: 2013-11-18 Impact factor: 5.191
Authors: Giuliana Ferrante; Salvatore Fasola; Giovanna Cilluffo; Giorgio Piacentini; Giovanni Viegi; Stefania La Grutta Journal: Front Public Health Date: 2022-06-14
Authors: Helen K Reddel; Maria Gerhardsson de Verdier; Alvar Agustí; Gary Anderson; Richard Beasley; Elisabeth H Bel; Christer Janson; Barry Make; Richard J Martin; Ian Pavord; David Price; Christina Keen; Asparuh Gardev; Stephen Rennard; Alecka Sveréus; Aruna T Bansal; Lance Brannman; Niklas Karlsson; Javier Nuevo; Fredrik Nyberg; Simon S Young; Jørgen Vestbo Journal: ERJ Open Res Date: 2019-02-01
Authors: Enrico Maiorino; Seung Han Baek; Feng Guo; Xiaobo Zhou; Parul H Kothari; Edwin K Silverman; Albert-László Barabási; Scott T Weiss; Benjamin A Raby; Amitabh Sharma Journal: Nat Commun Date: 2020-02-10 Impact factor: 14.919